CD9 and cancer: CD9 downregulation is a poor prognostic factor in many cancers, with CD9 expression inversely correlating with invasiveness in melanoma, breast carcinoma, squamous cell carcinoma, ovarian cancer, and cervical carcinoma [43-52].